U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for implementation of the Research on Eosinophil Associated Disorders (R21) Exploratory/Developmental Research Grant. The purpose of this grant is to encourage research aimed at elucidating the pathophysiology of eosinophil-associated disorders and clarifying the cellular and molecular mechanisms underlying the role of eosinophil leukocytes in these conditions. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these studies. Contractors should refer to . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | November 3, 2014

Federal Government Announces Research on Eosinophil Associated Disorders (R21) Exploratory/Developmental Research Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member